Door-to-Needle Time and Long-term Outcomes in Patients With Stroke

JAMA. 2020 Oct 13;324(14):1467. doi: 10.1001/jama.2020.15185.
No abstract available

Publication types

  • Comment

MeSH terms

  • Brain Ischemia*
  • Fibrinolytic Agents
  • Humans
  • Patient Readmission
  • Stroke*
  • Tissue Plasminogen Activator

Substances

  • Fibrinolytic Agents
  • Tissue Plasminogen Activator